NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...

In the six weeks since the Food and Drug Administration authorized updated omicron boosters, it’s been unclear how much more protection the new version of the shot provides against infection. On ...

The MarketWatch News Department was not involved in the creation of this content. -- Strengthened Commercial Execution Driving Topline Growth -- Continued Progress Across R&D Pipeline -- Expanded ...

As the spring saw another surge of coronavirus cases across the country, healthcare officials are urging people to get vaccinated. But some social media posts are spreading false claims that the ...

Pfizer's stock decline is linked to reduced 2026 revenue forecasts due to lower Covid vaccine sales and patent expirations. The company prioritizes development investments over share repurchases, ...

President Donald Trump has demanded that pharmaceutical companies such as Pfizer release what he described as hidden COVID-19 vaccine data, raising questions about the legacy of Operation Warp Speed, ...

US President Donald Trump has demanded that pharmaceutical companies, including Pfizer, release detailed data on the effectiveness of their COVID-19 drugs and vaccines. Trump, while speaking on his ...

By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...